Skip to main content

Table 1 Study description

From: Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review

Study (country)

Scoring systems

Sample size (age in years)

(Outcome) and model performance measures

Study (country)

Scoring system

Sample size (age in years)

(Outcome) and model performance measures

Abhinandan and Vedavathi, 2013 (India) [60]

APACHE II

50 (18–90, mean 48.36)

(Unspecified mortality) D: not reported; C: not reported; CM: not reported; comparison of means

Liu et al., 2016 (China) [61]

APACHE II

137 (mean 69.53 ± 9.28)

(Hospital mortality) D: AUROC; C: not reported; CM: sensitivity, specificity

Aggarwal et al., 2006 (India) [7]

APACHE II

SAPS II

MPM II 0

MPM II 24

459 (16–80)

(Hospital mortality) D: AUROC; C: HL C and H statistics; CM: sensitivity, specificity, NPV, PPV, accuracy

Mohan et al., 2015 (India) [46]

APACHE II

SAPS II

SAPS 3

100 (mean: survivors 44.29 ± 15.53, non-survivors 57.37 ± 20.42)

(ICU mortality) D: not reported; C: not reported; CM: sensitivity, specificity; comparison of means

Ahluwalia et al., 1999 (India) [29]

APACHE II 48 hours (TA) New Scorea

79 (13–80, mean 46)

(Hospital mortality) D: AUROC (CI not reported); C: not reported; CM: sensitivity, specificity

Nair et al., 2016 (India) [62]

SAPS

48 (mean: survivors 53.56, non-survivors 47.78)

(ICU mortality) D: AUROC;

C: not reported

Celik et al., 2014 (Turkey) [63]

SAPS II

545 (>18)

(ICU mortality) D: not reported; C: not reported; CM: not reported; comparison of means

Naqvi et al., 2016 (Pakistan) [33]

APACHE II

SAPS

96 (mean 32.93 ± 16.61)

(ICU mortality) D: AUROC; C: HL

Chang et al., 2006 (Taiwan) [64]

APACHE II

1263 (13–92, mean 56)

(Hospital mortality) D: AUROC; C: HL

Nassar et al., 2012 (Brazil) [42]

APACHE IV

SAPS 3

MPM III

5780 (median 66, IQR 47–79)

(Hospital mortality) D: AUROC; C: HL C statistic

Chiavone and Rasslan, 2005 (Brazil) [65]

APACHE II

94 (16–97)

(Hospital mortality) D: AUROC; C: calibration curve, stratified in 10% risk bands, R2

Naved et al., 2011 (Pakistan) [34]

APACHE II (48 hours)

253 (15–84, mean 51.26 ± 17.9)

(ICU mortality) D: not reported; C: chi-square test

Eapen et al., 1997 (India) [30]

APACHE II (VA)

500 (13–84)

(Unspecified mortality) D: AUROC (CI not reported); C: not reported

Nimgaonkar et al., 2004 (India) [35]

APACHE II

ANN22a

ANN15a

2962 (mean 37.5 ± 16.1)

(Hospital mortality) D: AUROC; C: HL

Evran et al., 2016 (Turkey) [47]

APACHE II

APACHE IV

SAPS 3

487 (18–96, mean 58.58 ± 18

(ICU mortality) D: AUROC (as figure); C: not reported; CM: sensitivity, specificity, accuracy, PPV and NPV

Nouira et al., 1998 (Tunisia) [66]

APACHE II

SAPS II

MPM 0

MPM 24

1325 (mean 46.6 ± 20.4)

(Hospital mortality) D: AUROC; C: HL C and H statistics; CM: NPV, PPV

Fadaizadeh et al., 2012 (Iran) [67]

APACHE II

SAPS II

415 (mean 49.28 ± 0.94)

(ICU mortality) D: AUROC; C: HL C statistic; CM: sensitivity, specificity

Ratanarat et al., 2005 (Thailand) [68]

APACHE II

SAPS I

482 (mean 56 ± 21)

(ICU mortality) D: AUROC; C: not reported

CM: sensitivity, specificity

Faruq et al., 2013 (Bangladesh) [37]

APACHE II

SAPS II

194 (mean 61.06 ± 15.42

(ICU mortality) D: AUROC; C: HL C statistic

Riviello et al., 2016 (Rwanda) [43]

MPM III (0)

R-MPMa

Simplified R-MPMa

427 (median 34, IQR 25–47)

(Hospital mortality) D: AUROC; C: HL

Galal et al., 2013 (Egypt) [49]

APACHE II

SAPS II

105 (0–88, mean 54.59 ± 15.75)

(ICU mortality) D: AUROC (CI not reported); C: HL; CM: sensitivity, specificity, accuracy

Sathe and Bapat, 2014 (India) [69]

APACHE II

SAPS II

1543 (mean 53.9 ± 16.8)

(Hospital mortality) D: AUROC; C: HL

Gilani et al., 2014 (Iran) [70]

APACHE II

APACHE III

SAPS II

202 (14–85 mean 53.1 ± 20.3)

(Hospital mortality) D: AUROC (CI not reported); C: HL; CM: sensitivity, specificity, accuracy, NPV, PPV

Sekulic et al., 2015 (Serbia) [48]

APACHE II

MPM II (0)

MPM II (24)

MPM II (48)

MPM II (72)

MPM II (7 days)

SAPS II

60 (mean 59.0 ± 15.8)

(ICU mortality) D: AUROC (as figure for MPM II (24));

C: HL; CM: sensitivity, specificity

Godinjak et al., 2016 (Bosnia and Herzegovina) [31]

APACHE II

SAPS II

174 (19–87, mean 61.7 ± 16.3)

(Hospital mortality) D: AUROC; C: not reported; CM: sensitivity, specificity

Shoukat et al., 2016 (Pakistan) [71]

APACHE IV

155 (13–70, mean 38.39 ± 13.61)

(Unspecified mortality) D: not reported; C: not reported; CM: not reported; comparison of means

Gupta and Arora, 2004 (India) [72]

APACHE II

330 (mean 43.32 ± 16.22)

(ICU mortality) D: AUROC (CI not reported); C: HL; CM: accuracy

Shrestha et al., 2011 (Nepal) [73]

APACHE III

117 (16–84, mean 43.18 ± 18.49)

(ICU mortality) D: AUROC; C: HL; CM: sensitivity, specificity, NPV, PPV, accuracy

Haidri et al., 2011 (Pakistan) [74]

APACHE II

142 (15–90, mean 53.16 ± 19.29)

(ICU mortality) D: not reported; C: not reported; comparison of means

Silva Junior et al., 2010 (Brazil) [55]

SAPS 3

1310 (mean 67.1 ± 15.3)

(Hospital mortality) D: AUROC; C: HL C statistic;

CM: sensitivity, specificity

Halim et al., 2009 (Indonesia) [75]

APACHE II

144 (15–85, mean 47.33 ± 17.17)

(ICU mortality) D: AUROC (CI not reported); C: HL; CM: sensitivity, specificity, accuracy, NPV, PPV

Soares and Salluh, 2006 (Brazil) [39]

SAPS II

SAPS 3

SAPS 3 (CSA)

952 (>18, mean 58.3 ± 23.1)

(Hospital mortality) D: AUROC; C: HL C statistic

Hamza et al., 2009 (Egypt) [76]

APACHE IV

SAPS II

MPM II0

265 (mean 57.07 ± 16.6)

(ICU mortality) D: AUROC; C: HL H statistic

Soares et al., 2004 (Brazil) [40]

APACHE II

APACHE III

SAPS II,

MPM II 0

MPM II 24

1257 (18–93, mean 56.0 ± 16.7)

(Hospital mortality) D: AUROC; C: HL H statistic

Hashmi et al., 2016 (Pakistan) [77]

APACHE II APACHE II (MTA)

213 (mean 46.31 ± 18.43)

(Unspecified mortality) D: AUROC; C: HL; CM: sensitivity, specificity, accuracy

Soares et al., 2010 (Brazil) [41]

SAPS II

SAPS 3

SAPS 3 (CSA)

MPM III (24)

717 (mean 61.2 ± 15.4)

(Hospital mortality) D: AUROC; C: HL C statistic

Hernandez et al., 2014 (Philippines) [78]

SAPS 3

2426 (mean 62 ± 17)

(ICU mortality) D: AUROC (CI not reported); C: HL C statistic

Sutheechet, 2009 (Thailand) [79]

SAPS II

MPM II (24)

639 (18–100, mean 56.9 ± 20.6)

(Hospital mortality) D: AUROC;

C: HL; CM: sensitivity, specificity, accuracy, NPV, PPV

Hosseini and Ramazani, 2015 (Iran) [80]

APACHE II

150 (3–97)

(ICU mortality) D: AUROC; C: HL; CM: sensitivity, specificity, accuracy

Teoh et al., 1991 (Malaysia) [81]

APACHE II

100 (1 month–82 years)

(Hospital mortality) D: not reported; C: not reported; CM: not reported; correlation

Juneja et al, 2012 (India) [1]

APACHE II

APACHE III

APACHE IV

SAPS II

SAPS 3

MPM II (0)

MPM III (0)

653 (mean 58.48 ± 18.6)

(ICU mortality) D: AUROC; C: HL; CM: sensitivity, specificity

Turner et al., 1989 (South Africa) [36]

APACHE II

728 (12–88, mean 43)

(Unspecified mortality) D: not reported; C: not reported; CM: not reported; correlation

Khan et al., 2015 (India) [32]

APACHE II

APACHE II (48 hours)

SAPS II

SAPS II (48 hours)

85 (mean 39.14 ± 17.3)

(Hospital mortality) D: AUROC; C: not reported; CM: sensitivity, specificity

Wilairatana et al., 1995 (Thailand) [82]

APACHE II

APACHE III

SAPS II

209 (16–93, mean 55.36 ± 17.44)

(Hospital mortality) D: AUROC; C: not reported;

CM: sensitivity, specificity, accuracy

Khawannimit and Geater, 2007 (Thailand) [38]

APACHE II

SAPS II

1316 (mean 55.6 ± 18.2)

(Hospital mortality) D: AUROC; C: HL C and H statistics; CM: sensitivity, specificity, NPV, PPV, accuracy

Xing et al., 2015 (China) [52]

APACHE II

APACHE IV

SAPS 3

981 (mean 64.8 ± 12.1)

(Hospital mortality) D: AUROC; C: HL C statistic

Khwannimit and Bhurayanontachai, 2011 (Thailand) [51]

APACHE II

SAPS 3

SAPS 3 (AUS)

SAPS II

Customised APACHE II (recalibration)

Customised SAPS II (recalibration)

Customised SAPS 3 (recalibration)

2022 (median 62, IQR 49–73)

(Hospital mortality) D: AUROC; C: HL H and C statistic

Yamin et al., 2011 (Pakistan) [28]

APACHE IV

162 (9–90, mean 38.024)

(ICU mortality) D: not reported; C: not reported; CM: accuracy; comparison of means

Kiatboonsri and Charoenpan, 1995 (Thailand) [45]

APACHE II

334 (15–98, mean 56.01 ± 18.23)

(Hospital mortality) D: AUROC not reported; C: not reported; CM: sensitivity, specificity, PPV, accuracy

Zhao et al., 2013 (China) [50]

SAPS II (initial)

SAPS II (48 hours)

SAPS II (24 hours)

SAPS II (72 hours)

Simplified SAPS II (VA)

1684 (18–98, mean 58.93 ± 18.30)

(ICU mortality) D: AUROC; C: HL; CM: sensitivity, specificity, accuracy; correlation

  1. a New model development
  2. VA variable adjustment, MTA modelling technique adjustment, D discrimination, AUROC area under the receiver operating characteristic curve, C calibration, HL Hosmer–Lemeshow statistic, CM classification measures (e.g. sensitivity, specificity, PPV positive predictive values, NPV negative predictive values, APACHE Acute Physiology and Chronic Health Evaluation, ANN artificial neural network, SAPS Simplified Acute Physiology Score, SAPS (AUS) Simplified Acute Physiology Score (Australian), SAPS (CSA) Simplified Acute Physiology Score (Central and South American), MPM Mortality Probability Models, R-MPM Rwanda-Mortality Probability Model, ICU intensive care unit, IQR interquartile range, CI confidence interval